Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.5900
-0.1741 (-22.78%)
At close: Jan 29, 2026, 4:00 PM EST
0.5916
+0.0016 (0.27%)
After-hours: Jan 29, 2026, 6:07 PM EST

Aprea Therapeutics Revenue

Aprea Therapeutics had revenue of $1.85K in the quarter ending September 30, 2025, a decrease of -99.48%. This brings the company's revenue in the last twelve months to $488.24K, down -62.75% year-over-year. In the year 2024, Aprea Therapeutics had annual revenue of $1.50M with 157.63% growth.

Revenue (ttm)
$488.24K
Revenue Growth
-62.75%
P/S Ratio
9.55
Revenue / Employee
$61,030
Employees
8
Market Cap
4.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.50M919.35K157.63%
Dec 31, 2023583.23K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

APRE News

More News